RESUMEN
OBJECTIVES: Convallatoxin (CNT) is a natural cardiac glycoside extracted from lily of the valley ( Convallaria majalis ). Although it is empirically known to cause blood coagulation disorders, the underlying mechanism remains unclear. CNT exerts cytotoxicity and increases tissue factor (TF) expression in endothelial cells. However, the direct action of CNT on blood coagulation remains unclear. Therefore, herein, we investigated the effects of CNT on whole blood coagulation system and TF expression in monocytes. METHODS: Blood samples were collected from healthy volunteers to measure plasma thrombin-antithrombin complex (TAT) concentration using ELISA and to perform rotational thromboelastometry (ROTEM) and whole-blood extracellular vesicle (EV)-associated TF (EV-TF) analysis. The effects of CNT were also investigated using the monocytic human cell line THP-1. Quantitative real-time PCR and western blotting were performed, and PD98059, a mitogen-activated protein kinase (MAPK) inhibitor, was used to elucidate the action mechanism of CNT-mediated TF production. RESULTS: CNT treatment increased EV-TF activity, shortened the whole blood clotting time in rotational thromboelastometry analysis, and increased TAT levels, which is an index of thrombin generation. Furthermore, CNT increased TF mRNA expression in THP-1 cells and EV-TF activity in the cell culture supernatant. Therefore, CNT may induce a hypercoagulable state with thrombin generation, in which elevated EV-TF activity derived from monocytes might be involved. These procoagulant effects of CNT were reversed by PD98059, suggesting that CNT-induced TF production in monocytes might be mediated by the MAPK pathway. CONCLUSIONS: The findings of the present study have further clarified the procoagulant properties of CNT.
Asunto(s)
Vesículas Extracelulares , Trombofilia , Humanos , Tromboplastina/metabolismo , Monocitos/metabolismo , Trombina/farmacología , Trombina/metabolismo , Células Endoteliales/metabolismo , Vesículas Extracelulares/metabolismo , Trombofilia/etiología , Inhibidores de Proteínas Quinasas/farmacologíaRESUMEN
Duodenal gastrointestinal stromal tumors (D-GISTs) are a rare and relatively small subset of GISTs whose imaging features are not well known. The present study aimed to evaluate the enhancement pattern of D-GISTs compared with that of gastric GISTs (G-GISTs) using dynamic computed tomography. This single-center, retrospective, clinicopathological analysis was conducted on 10 patients with D-GISTs who underwent surgery between June 2006 and October 2018. In the same period, 25 patients with G-GISTs underwent surgery and were enrolled. The contrast ratio was defined as the ratio between Hounsfield units in contrast enhanced and unenhanced images in different phases, and these ratios were compared between the D-GIST and G-GIST groups. Furthermore, microvessel density, analyzed by immunohistochemical staining for CD31, was compared between the D-GIST and G-GIST groups. The contrast ratio of D-GIST was significantly higher than that of G-GIST in the arterial, portal and delayed phases (P<0.01, P<0.01 and P=0.02, respectively). The microvessel density of the D-GISTs was significantly higher than that of the G-GISTs (P<0.0001). D-GISTs were more hypervascular than G-GISTs on both imaging and pathological analyses.
RESUMEN
BACKGROUND: Convallotoxin (CNT), present in lily of the valley (Convallaria majalis), is a toxin that causes food poisoning among humans and companion animals. Although various symptoms of CNT poisoning have been well described, hypercoagulability owing to CNT is only empirically known among some veterinarians, and the underlying mechanism remains to be elucidated. CNT exerts cytotoxic effects on endothelial cells. OBJECTIVES: This study aimed to determine whether CNT induces the expression of tissue factor (TF), a potent initiator of the extrinsic coagulation cascade, in endothelial cells and leads to a hypercoagulable state. METHODS: Human umbilical vein endothelial cells (HUVECs) were used for in vitro experiments. HUVECs were treated with or without CNT (50 and 100 nM) for 4 h. Phosphate-buffered saline was used as a control. Cell viability was determined using the WST-8 assay. Quantitative real-time polymerase chain reaction was performed to determine TF mRNA expression. TF protein expression was observed using a laser scanning confocal microscope. RESULTS: The viability of HUVECs significantly reduced after CNT treatment compared with that of non-treated cells (p < 0.05). Moreover, a significant increase in TF mRNA and protein expression was observed after 4 h of CNT treatment. CNT elicited these effects in a dose-dependent manner. CONCLUSIONS: TF expression induced by CNT in endothelial cells can contribute to the development of a hypercoagulable state. The present study partially revealed the mechanisms underlying the CNT-induced hypercoagulable state. The findings can contribute to the development of a novel therapy for lily of the valley poisoning.
Asunto(s)
Glicósidos Cardíacos , Convallaria , Animales , Convallaria/metabolismo , Células Endoteliales/metabolismo , Estrofantinas , Tromboplastina/genética , Tromboplastina/metabolismoRESUMEN
We report a case of sudden death due to acute coronary syndrome (ACS) in a young cannabis user. A man in his late thirties died at home, and marijuana was found. The autopsy revealed severe occlusion by an atherosclerotic plaque in the left anterior descending artery. The histopathological examination revealed ischemic changes, likely caused by cannabis-induced sympathetic ß-adrenergic stimulation. Both cannabinoid receptors (CB1 and CB2) were expressed in the atherosclerotic lesions. The CB2 expression was higher than CB1 expression in the atherosclerotic plaque, corresponding to macrophage infiltration. Since cannabis is regarded as a casual drug due to its lower levels of dependency, some individuals have supported legalized marijuana use. However, this case report will provide cautions on the casual use of cannabis.
Asunto(s)
Cannabis , Alucinógenos , Fumar Marihuana , Cannabis/efectos adversos , Vasos Coronarios , Muerte Súbita Cardíaca/etiología , HumanosAsunto(s)
Aneurisma Infectado/diagnóstico por imagen , Aneurisma de la Aorta/diagnóstico por imagen , Fluorodesoxiglucosa F18 , Tomografía Computarizada por Tomografía de Emisión de Positrones , Radiofármacos , Anciano , Aneurisma Infectado/terapia , Aneurisma de la Aorta/terapia , Femenino , Humanos , Factores de TiempoRESUMEN
To investigate the relationship between blood thyroglobulin (Tg) levels and neck compression, the Tg levels of right cardiac blood were measured using a chemiluminescence immunoassay in 256 autopsy cases. There were 11 cases in which neck compression was confirmed based on autopsy findings and other information, in which the mean Tg level was 3155â¯ng/mL (range: 179-16,500â¯ng/mL). In the remaining cases, the mean Tg level was 4160â¯ng/mL (range: 0.3-139,000â¯ng/mL). There was no significant difference between the mean Tg levels of the two groups. In a comparison between the case groups with Tg levels of ≥200â¯ng/mL and <200â¯ng/mL, it was found that the frequency of neck compression was significantly higher (Pâ¯<â¯0.05) in the ≥200â¯ng/mL group. The frequency of high Tg levels (≥200â¯ng/mL) was increased among the cases in which death was caused by neck compression or asphyxia. In a comparison of the median Tg values of right heart blood, left heart blood, whole blood, and femoral venous blood, the median Tg values of whole blood and right heart blood were shown to be about 10 times higher than those of left heart blood and peripheral blood. It is said that high postmortem blood Tg levels are caused by mechanical compression of the thyroid gland. However, high Tg levels were detected in the half of the cases without neck compression. Therefore, neck compression should be diagnosed carefully based on autopsy findings and other information.
Asunto(s)
Asfixia/diagnóstico , Traumatismos del Cuello/diagnóstico , Tiroglobulina/sangre , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Patologia Forense , Humanos , Inmunoensayo , Lactante , Recién Nacido , Luminiscencia , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Glándula Tiroides/patología , Adulto JovenRESUMEN
To examine whether polymorphic mtDNA mutations that do not induce significant respiration defects regulate phenotypes of tumor cells, we used mouse transmitochondrial tumor cells (cybrids) with nuclear DNA from C57BL/6 (B6) strain and mtDNA from allogenic C3H strain. The results showed that polymorphic mutations of C3H mtDNA in the cybrids induced hypoxia sensitivity, resulting in a delay of tumor formation on their subcutaneous inoculation into B6 mice. Therefore, the effects of polymorphic mutations in normal mtDNA have to be carefully considered, particularly when we apply the gene therapy to the embryos to replace their pathogenic mtDNA by normal mtDNA.
Asunto(s)
ADN Mitocondrial/genética , Mutación , Neoplasias Experimentales/genética , Polimorfismo Genético , Acetilcisteína/farmacología , Animales , Western Blotting , Electroforesis en Gel de Poliacrilamida , Ratones , Ratones Endogámicos C57BL , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Especies Reactivas de OxígenoRESUMEN
Mitochondrial DNA (mtDNA) has been proposed to be involved in respiratory function, and mtDNA mutations have been associated with aging, tumors, and various disorders, but the effects of mtDNA imported into transplants from different individuals or aged subjects have been unclear. We examined this issue by generating trans-mitochondrial tumor cells and embryonic stem cells that shared the syngenic C57BL/6 (B6) strain-derived nuclear DNA background but possessed mtDNA derived from allogenic mouse strains. We demonstrate that transplants with mtDNA from the NZB/B1NJ strain were rejected from the host B6 mice, not by the acquired immune system but by the innate immune system. This rejection was caused partly by NK cells and involved a MyD88-dependent pathway. These results introduce novel roles of mtDNA and innate immunity in tumor immunology and transplantation medicine.